Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study
Debbie A Lawlor, George Davey Smith, Shah Ebrahim A large cohort study of nearly 15 000 individuals found that indicators of insulin sensitivity were associated with increased risk of suicide. 1 The authors assumed that insulin resistance was the key factor responsible. Insulin resistance is a determinant of free fatty acids in the blood, which are in turn important in tryptophan metabolism and brain serotonin concentrations. 2 3 Individuals who are insulin resistant may therefore have higher serotonin concentrations and as a result be less likely to be depressed. 1 We know of no previous study that has assessed the association between insulin resistance and depression in humans.
Participants, methods and results
We assessed this association in a cross sectional analysis of 4286 women aged 60-79 who were randomly selected from general practitioners' lists in 23 British towns. 4 We used the homoeostasis model assessment method (HOMA score), derived from fasting insulin and glucose concentrations to assess insulin resistance. 4 We used three indicators of depression: current use of antidepressant medication, self report of ever having received a diagnosis of depression from a doctor, and the EQ5D mood question of the EuroQOL. 5 Participants brought all of their medications to an interview with a nurse. We used the British National Formulary (www.bnf.org/) to code medications; "antidepressants" included any medication in section 4.3. Participants whose response to the EQ5D mood question was that they were "today feeling either moderately or extremely anxious and/or depressed" were coded as currently anxious or depressed.
We categorised women without diabetes into quarters of HOMA score and added a fifth category of women with diabetes. We estimated proportions of women with depression for each of these HOMA score and diabetes categories. We used multiple logistic regression to assess the effect of insulin resistance on depression, with adjustment for potential confounding factors. In all analyses we used robust standard errors, allowing for potential clustering between women from the same town, to calculate confidence intervals and P values.
The prevalence of depression decreased linearly with increasing insulin resistance among women without diabetes and then increased among women with diabetes ( figure) . The age adjusted odds ratio (95% confidence interval) of current antidepressant use per increase in one category (quarters of the distribution) of HOMA score among non-diabetic women was 0.86 (0.76 to 0.96, P = 0.01). Similar results for ever being diagnosed with depression and reporting feeling anxious or depressed were 0.84 (0.74 to 0.97, P = 0.006) and 0.89 (0.79 to 0.99, P = 0.04). None of these associations was altered by further adjustment for waist:hip ratio, body mass index, smoking, alcohol consumption, physical activity, and social class during adulthood and childhood.
Comment
Insulin resistance is inversely associated with depression. Our results are consistent with a large prospective study in which indicators of insulin sensitivity were associated with suicide risk. 1 The explanation for the reverse J shaped association seen when diabetes was included as a fifth category alongside insulin resistance may be due to patients with a clinical diagnosis of diabetes developing depression as a result of this diagnosis.
We based our assessment of depression on current use of medication and self reports of past diagnoses and current mood rather than clinical assessment with international diagnostic criteria. However, the consistency of our findings across the three different assessments supports a causal association, and any measurement error in our assessment of depression would tend to dilute the results. Insulin resistance is positively associated with diabetes and cardiovascular disease, and we do not believe that our results should be used to discourage appropriate interventions to prevent and treat insulin resistance. Further, these are novel findings and need to be replicated in other studies. However, if our findings are confirmed there may be an indication for assessing depressive symptoms among individuals receiving treatments that affect insulin resistance, since depressive symptoms are often disabling and could affect compliance with treatment and quality of life.
The British Women's Heart and Health Study is codirected by SA, Peter Whincup, Goya Wannamethee, and DAL. We thank Carol Bedford, Alison Emerton, Nicola Frecknall, Karen Jones, Rita Patel, Mark Taylor, and Katherine Wornell for collecting and entering data, all of the general practitioners and their staff who have supported data collection, and the women who have participated in the study. Contributors: All authors developed the study aim and design. DAL undertook the initial analysis and coordinated writing of the paper. All authors contributed to the final version. DAL acts as guarantor. 
